GNS Healthcare today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, to its strategic advisory board.
CAMBRIDGE, Mass., Sept. 18, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, today announced the appointment of Ziad Obermeyer, MD, Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, to its strategic advisory board. Dr. Obermeyer is an emergency physician and researcher who works at the intersection of machine learning and health, using technology to provide better care for patients and drive innovations in research.
“Ziad is a strong advocate for using data and technology to provide better care to patients. We are excited to have his expertise on our advisory board as we continue to develop and refine solutions that can be translated into real outcomes for patients,” said Colin Hill, Chairman, CEO, and Co-Founder of GNS Healthcare. “As the industry continues to embrace the value of precision medicine, I can’t think of anyone better to help us understand what that means for patients, and for clinically-inspired research.”
Dr. Obermeyer earned his MD (magna cum laude) at Harvard Medical school and completed his clinical residency in emergency medicine at the Brigham & Women’s, Massachusetts General, and Boston Children’s Hospitals. He holds a bachelor’s degree from Harvard College and a Master of Philosophy from Cambridge University. In 2012 he received the Early Independence Awards from the High Risk--High Reward Portfolio of the Office of the Director of the National Institutes of Health. His work has been published in Science, The New England Journal of Medicine, JAMA, The BMJ, and Health Affairs.
“GNS is at the forefront of leveraging data and ground-breaking technology to unravel the complexity of human biology,” said Dr. Obermeyer. “I’m looking forward to collaborating with them to drive precision medicine to the point of care and make a real difference in how we develop and practice medicine.”
GNS Healthcare’s current SAB is comprised of leading researchers, clinicians and scientists including; Atul Butte, MD, PhD; Ted Goldstein, PhD; Randy Krakauer, MD; Isaac Kohane, MD, PhD; Richard Popiel, MD, MBA; David Sontag PhD; and Patrick Getzen. A full list of GNS SAB members can be found on website here.
Disclosures: Dr Obermeyer has elected to take this advisory position unpaid and without equity. No conflicts of interest were disclosed.
About GNS Healthcare
GNS Healthcare solves healthcare’s matching problem for leading health plans, biopharma companies, and health systems. We transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals, improving health outcomes and saving billions of dollars. Our causal learning and simulation platform, REFS, accelerates the discovery of what works for whom and why.
Media Contact:
Patty Kellicker
VP, Marketing
pkellicker@gnshealthcare.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/clinical-and-machine-learning-expert-dr-ziad-obermeyer-joins-gns-healthcares-strategic-advisory-board-300714498.html
SOURCE GNS Healthcare
